Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma symbols : Snynf save search
Innate Pharma Presents at AACR 2024 Preclinical Efficacy of Its Pre-IND Drug Candidate IPH45, a Novel Nectin-4 Antibody Drug Conjugate
Published: 2024-04-10 (Crawled : 09:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: -0.01%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.32%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: -3.85%
H: 1.2%
C: 0.8%
iph45 pharma drug candidate antibody preclinical
Innate Pharma Announces Its Participation in Upcoming April 2024 Investor Conference
Published: 2024-04-09 (Crawled : 09:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.38%
H: 0.95%
C: 0.83%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 2.57%
H: 1.81%
C: 1.81%
pharma conference
Innate Pharma Files Its 2023 Universal Registration Document (Document d’enregistrement Universel) and 2023 Annual Report on Form 20-F
Published: 2024-04-05 (Crawled : 11:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: -1.77%
H: 0.0%
C: -1.81%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -3.44%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: -0.4%
H: 0.0%
C: -5.22%
pharma report universal
Notice of Annual General Meeting of Vicore Pharma Holding AB (publ)
Published: 2024-04-04 (Crawled : 09:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.18%
H: 0.0%
C: 0.0%
pharma meeting
Innate Pharma Reports Full Year 2023 Financial Results and Business Update
Published: 2024-03-21 (Crawled : 09:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.14%
H: 0.24%
C: 0.24%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: -4.51%
H: 4.25%
C: 0.96%
pharma business year update financial results
Innate Pharma Announces Its Participation to Upcoming Investor Conference - March 19, 2024
Published: 2024-03-19 (Crawled : 08:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: -0.02%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -1.51%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 0.84%
H: 4.56%
C: 0.83%
pharma conference
Innate Pharma Announces Conference Call and Webcast for Full Year 2023 Financial Results
Published: 2024-03-14 (Crawled : 09:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.23%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: -2.4%
H: 3.69%
C: 3.28%
pharma conference year financial results
Vaccine research market size to grow at a CAGR of 9.88% from 2022 to 2027, Abbott Laboratories, Astellas Pharma Inc., AstraZeneca Plc, more to emerge as key players, Technavio
Published: 2024-03-11 (Crawled : 14:30) - prnewswire.com
CMXHF | $180.75 -19.21% 33
|
n/a
|
| O: 0.41%
H: 0.0%
C: 0.0%
CSLLY | $91.51 3.3% 18K
|
n/a
|
| O: -4.92%
H: 3.76%
C: 3.44%
GLAXF | $20.07 -14.18% 1K
|
Health Technology
|
| O: -3.4%
H: 1.49%
C: 1.49%
AZNCF | $138.88 -4.19% 960
|
Health Technology
|
| O: 1.55%
H: 0.82%
C: 0.16%
ALPMY | $9.55 -1.11% 300K
|
Manufacturing
|
| O: -1.41%
H: 5.06%
C: 4.01%
GSK | $40.5 -0.39% -0.03% 2.8M
|
Health Technology
|
| O: -0.6%
H: 0.19%
C: 0.09%
ABT | $108.89 -0.2% 0.04% 4.6M
|
Health Technology
|
| O: 0.26%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.57%
H: 0.0%
C: 0.0%
AZN | $68.75 -0.26% -0.26% 7.6M
|
Health Technology
|
| O: 1.08%
H: 0.82%
C: 0.67%
pharma vaccine astrazeneca research key market
Innate Pharma to Present Nectin-4 Antibody Drug Conjugate IPH45 Preclinical Data at AACR 2024
Published: 2024-03-06 (Crawled : 11:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.0%
H: 0.8%
C: 0.8%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.45%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 0.78%
H: 1.93%
C: 0.97%
iph45 pharma drug antibody preclinical
Zealand Pharma Announces Financial Results for the Full Year 2023
Published: 2024-02-27 (Crawled : 06:00) - globenewswire.com
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.94%
H: 0.0%
C: 0.0%
pharma year financial results
Innate Pharma Announces Its Participation to Upcoming March 2024 Investor Conference
Published: 2024-02-21 (Crawled : 07:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 1.7%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.57%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: -2.32%
H: 0.0%
C: 0.0%
pharma conference
Number of Shares and Voting Rights of Innate Pharma as of January 1, 2024
Published: 2024-01-12 (Crawled : 11:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.71%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.06%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 0.0%
H: 0.36%
C: 0.36%
pharma
Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries
Published: 2024-01-08 (Crawled : 12:30) - prnewswire.com
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 2.07%
H: 0.48%
C: 0.48%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.16%
H: 0.0%
C: 0.0%
REGN | $898.33 -0.7% -0.71% 650K
|
Health Technology
|
| O: -2.54%
H: 1.53%
C: 1.45%
libtayo pharma pharmaceuticals agreement
Innate Pharma Strengthens Leadership and Appoints Two New Members to Its Executive Board
Published: 2024-01-04 (Crawled : 09:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.12%
H: 0.93%
C: 0.77%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 6.47%
H: 3.65%
C: -2.36%
pharma
Innate Pharma Announces U.S. FDA Lifts Partial Clinical Hold on Lacutamab Clinical Program
Published: 2024-01-04 (Crawled : 08:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 1.62%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.12%
H: 0.93%
C: 0.77%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 6.47%
H: 3.65%
C: -2.36%
fda pharma program
Innate Pharma Announces Licensing of a Fourth Natural Killer Cell Engager in Oncology to Sanofi
Published: 2023-12-19 (Crawled : 08:00) - biospace.com/
NVO | $123.9 -0.49% 0.23% 2.9M
|
Health Technology
|
| O: 0.91%
H: 0.72%
C: 0.11%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 0.45%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 13.88%
H: 0.0%
C: -3.58%
pharma natural cell sanofi
Innate Pharma Announces Leadership Change - December 18, 2023
Published: 2023-12-18 (Crawled : 10:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.25%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 2.9%
H: 2.02%
C: -1.21%
pharma change
Biden, Big Pharma Increasingly at Loggerheads in Run-Up to 2024 Election
Published: 2023-12-15 (Crawled : 22:00) - biospace.com/
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: -0.93%
H: 0.0%
C: 0.0%
pharma
Innate Pharma Shares Efficacy and Safety Phase 1 /2 Results of NK Cell Engager SAR443579 / IPH6101 Developed by Sanofi at ASH 2023
Published: 2023-12-11 (Crawled : 08:00) - biospace.com/
IPHYF | $2.65 104.6% 300
|
Health Technology
|
| O: 9.45%
H: 0.0%
C: -1.7%
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: 0.5%
H: 1.67%
C: 0.1%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 2.15%
H: 0.0%
C: 0.0%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: -1.16%
H: 0.39%
C: -4.31%
sar4435 pharma iph6101 cell results sanofi
Innate Pharma to Host Virtual KOL Event on Lacutamab
Published: 2023-11-27 (Crawled : 11:00) - biospace.com/
SNYNF | $92.9 -2.18% 880
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
SNY | $46.22 0.63% 0.63% 1.7M
|
Health Technology
|
| O: 1.04%
H: 0.17%
C: 0.11%
IPHA | $2.48 3.88% 8.1K
|
Health Technology
|
| O: 2.07%
H: 1.21%
C: 1.21%
pharma
Gainers vs Losers
| 49% | 51% |
Top 10 Gainers
KAVL | $6.275 135.02% 57.45% 44M
|
Wholesale Trade
PXMD | $0.7375 79.09% 44.16% 4.5M
|
Health Technology
DYNT | $0.371 -5.12% 43.09% 3.3M
|
Health Technology
LGVN P 3 d | $2.94 73.96% 42.52% 57M
|
HUBC | $1.94 49.23% 32.99% 73M
|
n/a
SPCB | $0.4044 46.52% 31.75% 130M
|
Electronic Technology
ONVO | $1.34 32.66% 24.62% 54M
|
Health Technology
OMQS | $0.6869 32.1% 24.3% 3.6M
|
Professional, Scientific, and T...
SNPO | $10.555 29.67% 22.88% 4M
|
AMBI | $3.72 -26.77% 21.77% 9.8K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.